Fund Holdings — Enavate Sciences GP, LLC

Total Portfolio Value:
$176.54M
Total Bought:
$0
Total Sold:
$0
Net Transaction:
$0
Securities
▲▼
SharesValue
Q1 2025
▲▼
Q2 2025
▲▼
Change
▲▼
Q1 2025
▲▼
Q2 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Immunome, Inc.(IMNM)4,768,5834,768,5830$32.09M$44.35M25.12%+$12.26M
Sionna Therapeutics, Inc.(SION)2,478,0302,478,0300$25.92M$42.99M24.35%+$17.07M
Zenas BioPharma, Inc.(ZBIO)3,761,3593,761,3590$29.71M$36.45M20.65%+$6.73M
Upstream Bio, Inc.(UPB)2,459,7032,459,7030$15.05M$27.01M15.30%+$11.95M
Compass Therapeutics, Inc.(CMPX)7,788,1507,788,1500$14.80M$20.25M11.47%+$5.45M
CAMP4 THERAPEUTICS CORPORATION(CAMP)3,785,8023,785,8020$15.14M$5.49M3.11%-$9.65M
Page 1 of 1
Enavate Sciences GP, LLC — 13F Holdings — Q2 2025 | TickerTrail